Pacira BioSciences (PCRX) Other Non Operating Income (2010 - 2026)

Pacira BioSciences' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$135000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 103.07% year-over-year to -$135000.0 in Q1 2026; TTM through Mar 2026 was -$5.5 million, a 237.02% decrease from a year earlier, with the FY2025 full-year figure at -$983000.0, down 163.54% from the prior year.
• Other Non Operating Income fell to -$135000.0 in Q1 2026 per PCRX's latest filing, from $5.5 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $7.5 million in Q2 2024 and bottomed at -$16.9 million in Q1 2023.
• The 5-year median for Other Non Operating Income is -$159000.0 (2024), against an average of -$2.3 million.
• Across the five-year window, Other Non Operating Income slumped 22939.13% in 2022 and soared 2894.8% in 2024, its largest moves.
• Year by year, Other Non Operating Income stood at $81000.0 in 2022, then plunged by 432.1% to -$269000.0 in 2023, then plunged by 2833.46% to -$7.9 million in 2024, then soared by 169.26% to $5.5 million in 2025, then plunged by 102.47% to -$135000.0 in 2026.
• Per Business Quant, the three latest PCRX Other Non Operating Income figures stand at -$135000.0 (Q1 2026), $5.5 million (Q4 2025), and -$110000.0 (Q3 2025).